Publications by authors named "L T Sener"
Cerium oxide NPs (-CeO), with notable performance in various biological tests like redox activity, free radical scavenging, and biofilm inhibition, emerge as significant candidates to address issues in related areas. In this research, copper-decorated -CeO (Cu@-CeO) were first synthesized and then characterized using advanced techniques such as SEM-EDX, XRD, XPS, BET, and ICP-OES. The biochemical properties of the obtained Cu@-CeO nanostructure and its performance in polyethersulfone (PES) membranes were thoroughly investigated in this research study.
View Article and Find Full Text PDFPd (0) nanoparticles (NPs) distributed on lanthanum (III) oxide were ex situ generated from the reduction of Pd ions using NaBH as reducing agent. The Pd/LaO displayed good catalytic activity in H(g) releasing from the hydrazine-borane (HB) methanolysis reaction and it was identified by advanced techniques. Pd/LaO was found to be an active catalyst procuring three equiv.
View Article and Find Full Text PDFObjective: The purpose of this study was to evaluate the relationship of IL28B rs12979860 and rs8099917 polymorphisms with the clinical, histological, and virological outcomes of patients with chronic hepatitis B (CHB) also the treatment responses of patients who received Nucleos(t)ide analogs (NAs) therapy.
Methods: This study included 152 CHB patients who were underwent liver parenchymal biopsy. The IL28B rs12979860 and rs8099917 polymorphism were genotyped using the TaqMan assay.
Background And Aim: This study aimed to detect mutations in the HBV S gene and evaluate their relationship to occult hepatitis B virus (HBV) infection (OBI).
Methods: The study included 32 patients with negative serum HBsAg and HBV DNA who underwent liver biopsy due to different clinical indications defined as the OBI group and 32 patients who underwent liver biopsy due to chronic hepatitis B (CHB) as the comparison group. The HBV S gene region was amplified by Nested PCR, and Sanger sequencing was performed.
Article Synopsis
- Occult hepatitis B infection (OBI) occurs in individuals who test negative for hepatitis B surface antigen (HBsAg) but still have the virus's genome in their liver, indicated by the hepatitis B core antibody (anti-HBc).
- A study of 59 HBsAg-negative chronic hepatitis C patients found OBI in 27.1% of cases, particularly in those who were anti-HBc positive, while none had detectable serum HBV DNA.
- The study suggests that anti-HBc positivity is linked to liver injury progression and recommends screening for anti-HBc in chronic hepatitis C patients to monitor potential complications.